blog

Learn some of the key strategies Altasciences employs to ensure you have the participants you need for your studies.

Blood microsampling is a less invasive and simplified alternative to traditional venipuncture, and provides significant advantages in preclinical and clinical studies alike. This month's blog includes an overview, and additional information.

Choosing the right CRO as a partner for your drug development programs is a vitally important step to achieving critical decision making early on for important milestones, and ultimately getting your molecule from discovery to market efficiently.

Artificial intelligence, or AI, has been on the radar screen as a possible tool to improve drug development, and clinical trial design and conduct for some time. This month's blog covers some of the advancements.

Adverse drug reactions caused by individual drugs and drug combinations contribute to one of the top 10 causes of death in the United States. This blog offers insight on minimizing the risks with DDI studies.

In part 1 of this series, we discussed how gut bacteria affect your health. In this article, we offer some strategies for maintaining a healthy microbiota, from reputable sources, supported by science.